AMX0114
A114-001
Phase 1 small_molecule active
Quick answer
AMX0114 for ALS is a Phase 1 program (small_molecule) at Amylyx Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amylyx Pharmaceuticals
- Indication
- ALS
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active